Join our
Investor Newsletter

To receive Investor News as it is released please sign up

News Releases

Partnership with St. Joseph’s Health

November 9, 2021
RNS Number : 7276R Renalytix PLC 09 November 2021     Renalytix plc ("Renalytix" or the "Company")   St. Joseph's Health and Renalytix Partner to Advance Value-Based Kidney Health   in New York   Partnership expands doctor and patient access to advanced prognosis and coordinated care management of

Issue of shares and Total Voting Rights

November 1, 2021
RNS Number : 9254Q Renalytix PLC 01 November 2021       Renalytix plc (" Renalytix " or the " Company ")     Issue of shares and Total Voting Rights   NEW YORK , November 1,  2021 -  Renalytix plc (AIM: RENX) announces that it has issued and allotted 68,224 ordinary shares of 0.25 pence each in the

Renalytix Reports Full Year Fiscal 2021 Results

October 21, 2021
RNS Number : 7882P Renalytix PLC 21 October 2021   Renalytix plc (" Renalytix " or the " Company ")   Renalytix Reports Full Year Fiscal 2021 Results   LONDON and SALT LAKE CITY , October 21, 2021   - Renalytix plc   (NASDAQ: RNLX),  (LSE : RENX) an artificial intelligence-enabled in vitro

Renalytix to Report Q4 and Full Year Results

October 8, 2021
RNS Number : 4032O Renalytix PLC 08 October 2021     Renalytix plc ("Renalytix" or the "Company")   Renalytix to Report Fourth Quarter and Full Year Fiscal 2021 Financial Results on October 21   LONDON and SALT LAKE CITY , October 8, 2021 -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) today announced

VA Health System roll-out & VP sales appointment

October 7, 2021
RNS Number : 2788O Renalytix PLC 07 October 2021     Renalytix plc (" Renalytix " or the " Company ")   Renalytix Launching KidneyIntelX in Veterans Health Administration Hospitals   Jed Fulk Appointed Vice President Sales, Government Accounts   NEW YORK and SALT LAKE CITY , October 7, 2021   -

Second Price Monitoring Extn

September 16, 2021
RNS Number : 0377M Renalytix PLC 16 September 2021   Second Price Monitoring Extension A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes. Following the first price monitoring extension this

Second Price Monitoring Extn

September 15, 2021
RNS Number : 8680L Renalytix PLC 15 September 2021   Second Price Monitoring Extension A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes. Following the first price monitoring extension this

Price Monitoring Extension

September 15, 2021
RNS Number : 8670L Renalytix PLC 15 September 2021   Price Monitoring Extension The auction call period has been extended in this security by 5 minutes. Auction call extensions give London Stock Exchange electronic order book users a further opportunity to review the prices and sizes of orders

Update on MCIT Rule

September 14, 2021
RNS Number : 7773L Renalytix PLC 14 September 2021   This announcement contains inside information   Renalytix plc (" Renalytix " or the " Company ")   Update on MCIT Rule to Provide National Medicare Coverage for FDA Breakthrough Devices and Diagnostics   NEW YORK , September 14, 2021 - Renalytix

Mount Sinai Initiates Scale-Up of KidneyIntelX

September 14, 2021
RNS Number : 6348L Renalytix PLC 14 September 2021   This announcement contains inside information   Renalytix plc (" Renalytix " or the " Company ")     Mount Sinai Initiates System-wide Scale-Up of Renalytix KidneyIntelX TM Enabled Health Care Model   Targeted testing run rate of 300 diabetic
Displaying 41 - 50 of 209